Here’s what AI said @Clumsykitten
When you inject a GLP-1 medication (like semaglutide, tirzepatide, liraglutide, etc.), the rise you see in “GLP-1 levels” over the following days isn’t your body suddenly making more hormone on its own—it’s mostly about how the drug is designed to behave in your body.
Here’s what’s going on:
1. The shot is made to release slowly
Most GLP-1 meds are formulated as slow-release molecules. After the jab:
- The drug sits in the fatty tissue under your skin
- It leaks into your bloodstream gradually
Blood levels climb over hours to days*, not minutes
That’s why peak levels don’t happen right away.
2. Long half-life = accumulation
Many GLP-1 drugs are engineered to stick around for a long time:
- They’re resistant to breakdown by DPP-4 (the enzyme that normally destroys GLP-1)
- Some bind to albumin or have fatty side chains that slow clearance
With weekly injections especially, levels build up over several days, then eventually reach a steady state after a few weeks.
3. It’s not just “GLP-1” — it’s a GLP-1–like signal
Blood tests and effects reflect:
The drug itself* (which acts like GLP-1 but isn’t identical)
- Ongoing receptor activation even as levels slowly rise
So functionally, your body is experiencing more GLP-1 activity, even if your gut isn’t producing extra native GLP-1.
4. Secondary effects can reinforce the signal
GLP-1 drugs also:
- Slow stomach emptying
- Improve insulin sensitivity
- Reduce glucose spikes
Those changes can alter normal gut hormone signaling, which may slightly change endogenous GLP-1 secretion—but that’s a minor contributor compared to the drug’s pharmacology.
Big picture
Your GLP-1 “levels” go up after the jab because:
The medication is absorbed slowly*
It’s designed to last*
Its effects accumulate over days*, not instantly
If you want, I can explain why side effects often peak a day or two later, or why weekly doses feel stronger over time.